IMPLANT360 Trademark

Trademark Overview


On Wednesday, March 8, 2023, a trademark application was filed for IMPLANT360 with the United States Patent and Trademark Office. The USPTO has given the IMPLANT360 trademark a serial number of 97828643. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, January 16, 2024. This trademark is owned by HemaTerra Technologies, LLC. The IMPLANT360 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring software in the field of managing and monitoring the distribution, inventory and use of medical tissue and devices for use by healthcare providers and healthcare facilities; Software as a service (SAAS) services featuring software in the field of developing and providing predictive analytics to determine best practices and purchasing cadences for medical tissue and devices; Software as a service (SAAS) services featuring software in the field of helping healthcare providers and healthcare facilities track all of their medical tissue and devices to meet FDA, regulatory and warranty requirements; Software as a service (SAAS) services featuring software in the field of collecting, synthesizing, analyzing and providing to third parties cost data, utilization data, and outcome data for medical procedures, physicians, and hospital medical activities; Software as a service (SAAS) services featuring software in the field of developing and providi...
implant360

General Information


Serial Number97828643
Word MarkIMPLANT360
Filing DateWednesday, March 8, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, January 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkIMPLANT THREE SIX ZERO; IMPLANT THREE HUNDRED SIXTY
Goods and ServicesSoftware as a service (SAAS) services featuring software in the field of managing and monitoring the distribution, inventory and use of medical tissue and devices for use by healthcare providers and healthcare facilities; Software as a service (SAAS) services featuring software in the field of developing and providing predictive analytics to determine best practices and purchasing cadences for medical tissue and devices; Software as a service (SAAS) services featuring software in the field of helping healthcare providers and healthcare facilities track all of their medical tissue and devices to meet FDA, regulatory and warranty requirements; Software as a service (SAAS) services featuring software in the field of collecting, synthesizing, analyzing and providing to third parties cost data, utilization data, and outcome data for medical procedures, physicians, and hospital medical activities; Software as a service (SAAS) services featuring software in the field of developing and providing predictive analytics to select cost-efficient and outcome-efficient medical tissue and devices for specified procedures

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 28, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHemaTerra Technologies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBaltimore, MD 21230

Trademark Events


Event DateEvent Description
Tuesday, January 16, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 16, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, January 16, 2024SUSPENSION LETTER WRITTEN
Saturday, January 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 6, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 6, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2023ASSIGNED TO EXAMINER
Tuesday, March 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 11, 2023NEW APPLICATION ENTERED